The transcription factor Foxp3 plays an indispensible role in the differentiation of regulatory T (Treg) cells and the expression of their suppressive functions. In a recent article published in Nature, Ouyang et al. demonstrate that Treg cell differentiation is also enabled by transcriptional networks controlled by another Forkhead box family member, Foxo1.
From flies to mammals, the forkhead box (Fox) family of transcription factors promotes the integration of environmental cues with cell metabolism and homeostasis [1] . In humans and mice, inactivation of the gene encoding the Foxp subfamily member 3 (Foxp3) results in aggressive, fatal multi-organ autoimmunity [2] . Following these observations, Foxp3 was quickly shown to be essential for the development and function of regulatory T (Treg) cells. However, experiments that replaced Foxp3 with EGFP or a non-functional Foxp3-EGFP fusion protein showed that developing Treg cells, although lacking regulatory function, retained a portion of the Treg cell transcriptome [3, 4] . These observations suggested that a higher order of transcriptional regulation was necessary in addition to Foxp3 expression for Treg cell development.
Additional Fox subfamily members (Foxo1 and Foxo3) are also expressed in lymphocytes, including T cells. Ablation of Foxo3 has little effect on T cell function and may result in a mild lymphproliferative and inflammatory syndrome, depending on the investigational approach [5, 6] . In contrast, T cell-specific deletion of Foxo1 produces peripheral T cell activation, increases the number of T cells producing IFN-γ and IL-17A, and increases autoantibody production [7, 8] . T cells in Foxo1-deficient mice have low levels of IL-7Rα and CD62L, which reduces naïve T cell survival. However, there is little effect of T cell-specific Foxo1 deficiency on thymic development, and the frequency of Foxp3
+ cells in the thymus, spleen, and lymph nodes of these mice is similar to controls. Importantly, mice with a compound deletion of Foxo1 and Foxo3 in T cells develop a lethal autoimmune inflammatory disease associated with reductions in Treg cell frequency, number, and function [9] . The cumulative data support the hypothesis that Foxo1 and Foxo3 act early in Treg cell lineage specification, while Foxp3 is a late-acting differentiation factor that maintains and stabilizes the Treg cell phenotype. Although expression of Foxo1 is upregulated in mature thymocytes and Foxo1 is expressed in peripheral Treg cells, the role of Foxo1 beyond Treg cell lineage specification has not been explored.
A recent paper by Ouyang et al. [10] has dissected the impact of Foxo1 expression on Treg cell function. In quiescent T cells, Foxo1 is found in the nucleus and shuttled to the cytoplasm following TCR engagement [1] . To interrogate the kinetics of Foxo1 translocation, the authors engineered a reporter allele that expresses Foxo1 fused in-frame to a green fluorescent protein, Flag, and a biotin-labeling peptide (Foxo1 
Foxo1
AAA/+ mice cross-referenced with the Foxo1 binding site data identified 310 direct target genes, many of which were associated with Jak-STAT, TCR and insulin signaling pathways. Interestingly, just 7%-10% of Foxo1-bound genes were also occupied by Foxp3 in other studies [11] . One of these genes, Ctla4, contributes to Treg cell suppressive function and is reported to be a direct target of both Foxp3 and Foxo1 [12] . In the current study, however, Treg cell-specific Foxo1 deficiency had minimal effects on CTLA4 expression and did not affect Treg cell-mediated in vitro suppression. Overall, the authors conclude that the majority of the Foxp3-dependent transcriptional program is intact in Foxo1-deficent mice, and that the loss of suppressive activity is not readily attributed to reductions in CTLA4.
Ouyang et al. also find that Foxo1 is recruited to a regulatory element near the Ifng transcriptional start site. In a fraction of Foxo1-deficient but not WT Treg cells, IFN-γ was induced after stimulation with IL-2, IL-12, and IFN-γ. This was not the case with WT and Foxo1-deficient Tconv cells, which produced similar amounts of IFN-γ under the same stimulating conditions. These data are consistent with a previous report showing that TGF-β signaling fails to repress the transcription factor T-bet in Foxo1-deficient T cells. To determine whether the IFN-γ produced by Foxo1-deficient Treg cells was related to their decreased suppressive function, the authors used a lymphopenia-associated transfer model of colitis. 
